Early Primary Tumor Size Reduction Is an Independent Predictor of Improved Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib
Early Primary Tumor Size Reduction Is an Independent Predictor of Improved Overall Survival in...
Abel, E. Jason;Culp, Stephen H.;Tannir, Nizar M.;Tamboli, Pheroze;Matin, Surena F.;Wood, Christopher G.;
2011-12-01 00:00:00
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngEuropean UrologyUnpaywallhttp://www.deepdyve.com/lp/unpaywall/early-primary-tumor-size-reduction-is-an-independent-predictor-of-ez05SOcDHd
Early Primary Tumor Size Reduction Is an Independent Predictor of Improved Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib
Early Primary Tumor Size Reduction Is an Independent Predictor of Improved Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.